• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION COYOTE; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION COYOTE; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number H74939186302210
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/18/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon rupture occurred.The 95% stenosed target lesion was located in the moderately tortuous and mildly calcified anterior tibial artery (ata).After the dilatation was performed in the left popliteal artery with 3.0mm x 220mm x 150cm coyote balloon catheter, the ata was attempted to be dilated.After crossing the lesion, the balloon was initially inflated at 6 atmospheres for 10 seconds.However, it ruptured before reaching the nominal pressure.The device was removed from the sheath without any problems, and the procedure was completed using a different balloon.No complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the device was returned for analysis.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed no damages.Microscopic examination revealed a longitudinal tear 8.6cm from the tip and is approximately 6.5cm long.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there is a longitudinal tear in the balloon.
 
Event or Problem Description
It was reported that balloon rupture occurred.The 95% stenosed target lesion was located in the moderately tortuous and mildly calcified anterior tibial artery (ata).After the dilatation was performed in the left popliteal artery with 3.0mm x 220mm x 150cm coyote balloon catheter, the ata was attempted to be dilated.After crossing the lesion, the balloon was initially inflated at 6 atmospheres for 10 seconds.However, it ruptured before reaching the nominal pressure.The device was removed from the sheath without any problems, and the procedure was completed using a different balloon.No complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COYOTE
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20843823
Report Number2124215-2024-76173
Device Sequence Number3838569
Product Code DQY
UDI-Device Identifier08714729797265
UDI-Public08714729797265
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K111295
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberH74939186302210
Device Catalogue NumberH74939186302210
Device Lot Number0032602948
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/19/2024
Supplement Date Received by Manufacturer12/18/2024
Initial Report FDA Received Date12/04/2024
Supplement Report FDA Received Date12/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/10/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-